NHS Framework Agreement for the supply of Prothrombin Complex Concentrate (PCC).
Contract notice
Supplies
Section I: Contracting authority
The Secretary of State for Health acting through the Commercial Medicines Unit (part of the Department of Health)
2nd Floor, Rutland House, Cheshire
For the attention of: Laura Boyle
WA7 2ES Runcorn
UNITED KINGDOM
Internet address(es):
General address of the contracting authority: https://cmu.bravosolution.co.uk
Further information can be obtained from: The above mentioned contact point(s)
Specifications and additional documents (including documents for competitive dialogue and a dynamic purchasing system) can be obtained from: The above mentioned contact point(s)
Tenders or requests to participate must be sent to: The above mentioned contact point(s)
Other: Public Procurement
The contracting authority is purchasing on behalf of other contracting authorities: yes
Please refer to the Invitation to Offer
Section II: Object of the contract
Purchase
Main site or location of works, place of delivery or of performance: The framework agreement is intended for use by the Department of Health and the NHS in England, Wales and Northern Ireland. The framework may also be used by private sector contractors and agents working on behalf of the above. Please refer to Document No.05d in the ITO documents for the list of Participating Authorities.
NUTS code
Duration of the framework agreement
Duration in months: 48Estimated total value of purchases for the entire duration of the framework agreement
Estimated value excluding VAT:Range: between 29 160 000 and 35 640 000 GBP
London end date: 31.12.2014. South of England end date: 30.6.2015. North of England (including Wales and Northern Ireland) end date: 31.12.2015. Midlands and East end date: 30.6.2016. The total maximum framework agreement period including extension options will be no more than 48 months.
Please refer to Document No.05d in the ITO documents for the list of Participating Authorities.
33141510, 33141520
Tenders may be submitted for one or more lots
Estimated value excluding VAT:
Range: between 29 160 000 and 35 640 000 GBP
Description of these options: This framework agreement has the option to be extended.
The total maximum framework agreement period including extensions will be no more than 48 months.
Information about lots
33141510, 33141520
Section III: Legal, economic, financial and technical information
Description of particular conditions: Please refer to the Invitation to Offer, Document No. 03, Conditions of Contract
Please refer to the award criteria contained in the Invitation to Offer
Section IV: Procedure
Section VI: Complementary information
1) Submission of expression of interest and procurement specific information
This procurement exercise will be conducted on the eTendering portal at www.cmu.bravosolution.co.uk Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested), through the eTendering portal as follows:
1.1) If not already registered, Candidates should register on the eTendering portal at https://www.cmu.bravosolution.co.uk and click the link to register:
- accept the terms and conditions and click continue,- enter your correct business and user details,
- note the username you chose and click 'Save' when complete,
- you will shortly receive an email with your unique password (please keep this secure).
1.2) Once registered, candidates must express interest as follows:
a. login to the eTendering portal;
b. select 'Response to ITT';
c. select 'ITTs Open To All Suppliers';
d. access listing related to this procurement : Prothrombin Complex Concentrate (PCC) and view details;
e. click on 'Express interest' button at the top of the page.
f. Once you have expressed interest, the ITT will move to 'My ITTs', where you can download additional documentation (if required), and construct your reply as instructed. You must then publish your reply using the 'Publish' button.
1.3) For any support in registering on the portal or submitting your expression of interest please contact the eTendering Help-desk at +44 8003684850 or
The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.Contracts awarded under a framework agreement may be awarded either: a) by application of the terms laid down in the framework agreement without reopening competition, or b) where not all the required terms of the proposed contracts are laid down in the framework agreement, by reopening competition between the economic operators which are parties to this framework agreement and which are capable of performing the proposed contract. Reopening of competition will be done in accordance with the procedure set out in Directive 2004/18/EC, Article 32.
Potential suppliers should note that, in accordance with the Government's policies on transparency, the Contracting Authority intends to publish the OJEU, ITO and the text of final contracts / framework agreements, subject to possible redactions at the discretion of the CMU (part of the Department of Health). Further information on transparency can be found at: https://www.gov.uk/government/policies/buying-and-managing-government-goods-and-services-more-efficiently-and-effectively